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Abstract 
Hepatic encephalopathy (HE) is a major complication of liver failure/disease 
which frequently develops during the progression of end-stage liver disease. This 
metabolic neuropsychiatric syndrome involves a spectrum of symptoms, including 
cognition impairment, attention deficits and motor dysfunction which eventually can 
progress to coma and death. Pathologically, HE is characterized by swelling of the 
astrocytes which consequently leads to brain edema, a common feature found in patients 
with acute liver failure (ALF) as well as in cirrhotic patients suffering from HE. The 
pathogenic factors involved in the onset of astrocyte swelling and brain edema in HE are 
unresolved. However, the role of astrocyte swelling/brain edema in the development of 
HE remains ambiguous and therefore measuring brain edema as an endpoint to evaluate 
HE is questioned. The following review will determine the effect of astrocyte swelling 
and brain edema on neurological function, discuss the various possible techniques to 
measure brain edema and lastly to propose a number of neurobehavioral tests to evaluate 
HE.    
 
Astrocyte swelling and brain dysfunction 
Astrocytes and disease 
 Astrocyte swelling has been implicated in a range of neurological disorders, 
involving stroke, migraine, epilepsy, and metabolic encephalopathies (including HE) 
(Felipo, 2013; Papadopoulos and Verkman, 2013; Thrane et al., 2014). Selective genetic 
(e.g. a mutation in glial fibrillary acid protein (GFAP) resulting in Alexander disease) or 
chemical impairment (fluorocitrate or fluoroacetate) of astrocyte function can also cause 
severe neurological impairment ranging from lethargy, stupor, ataxia, seizures to coma 
and death (Swanson and Graham, 1994; Messing et al., 2012). The cellular mechanisms 
causing these phenotypic manifestations can best be understood by first examining the 
physiological roles of astroglia.  
 
Fundamental role of astrocytes in the central nervous system 
Astrocytes are multifunctional glial cells responsible for key brain homeostatic 
functions such as regulating ion gradients, cerebral blood flow, blood-brain barrier (BBB) 
integrity, scar formation (reactive gliosis) and cellular metabolism (Ransom et al., 2003). 
They are electrically inactive, but signal with intracellular calcium and other secondary 
messengers (including adenosine triphosphate (ATP) and cyclic guanosine 
monophosphate (cGMP)) (Cotrina et al., 2000; Sun et al., 2013). The importance of 
astrocytes for more complex nervous systems is highlighted by the fact that evolution has 
selectively increased the size, relative abundance and complexity of these cells, whilst 
leaving neurons relatively unchanged (Oberheim et al., 2006). Collectively, neuroglia 
make up approximately 41% of the volume fraction of human cortex, compared to 27% 
by neurons, and 12% by interstitial fluid, with the remainder comprising blood (10%) and 
cerebrospinal fluid (CSF); 10%)) (Syková and Nicholson, 2008). Although astrocytes 
were initially seen as simple star shaped structural cells on silver-chromate and 
cytoskeletal (GFAP) staining, cytoplasmic labeling studies have revealed a more complex 
‘bush-like’ morphology (Oberheim et al., 2008). Individual astrocytes are linked together 
into a syncytium by gap junctions, which have been suggested to facilitate faster ion 
movement, metabolic trafficking and neurovascular coupling (Rose and Ransom, 1997; 
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Rouach et al., 2008). Astrocytes have an intricate subcellular anatomy, with thousands of 
specialized processes that express a different subset of transporters depending on whether 
they abut blood vessels (peri-vascular end-feet), CSF (sub-ependymal end-feet) or 
synapses (peri-synaptic processes). Peri-vascular processes, for instance, are selectively 
endowed with ion and water transport mechanisms (including Na+-K+-2Cl- cotransporter 
isoform 1(NKCC1), inwardly rectifying potassium channel Kir4.1, glutamate transporter-
1 (GLT1), glucose transporter (GLUT), Na+-K+-ATPase (NKA), system N transporter 
(SN1)), including the main brain water channel, aquaporin 4 (AQP4) (Figure 1). 
Metabolically, astrocytes are estimated to be responsible for about 30% of cerebral 
metabolism, and are amongst the most glycolytically active cells in the brain (Kasischke 
et al., 2004; Pellerin et al., 2007). Finally, a large body of evidence indicates that 
astrocytes play an active role in synaptic transmission (tripartite synapse), for instance by 
regulating neurotransmitter turnover and perhaps gliotransmission, along with fine-tuning 
the structural and electrochemical synaptic environment (Araque et al., 1999; Nedergaard 
and Verkhratsky, 2012). Therefore, astrocytes are critical cells which play a pivotal role 
in health and disease (Rose et al., 2013). 
 
Astrocytes: susceptible to swelling 
Astrocyte responses to osmotic stress have been extensively studied in vitro and 
in situ. Astrocytes are thought to be able to cope with brief exposures (30-90 min) to mild 
or moderate amounts of swelling by offloading osmolytes, including potentially 
excitotoxic neurotransmitters, a mechanism known as regulatory volume decrease (RVD) 
(Kimelberg, 1987; Ordaz et al., 2004; Thrane et al., 2011; Anderova et al., 2014). 
Conversely, hyper-osmotic stress may be able to induce a regulatory volume increase 
(RVI) by uptake of osmolytes and water (Evanko et al., 2004; Risher et al., 2009). The 
molecular mechanisms underlying this response are incompletely understood, and 
thought to involve osmo- or stretch-sensitive intracellular signaling cascades involving 
[Ca2+]I transients, AQP4 and volume-regulated anion channels (VRACs) (Mulligan and 
MacVicar, 2006; Thrane et al., 2011; Qiu et al., 2014; Voss et al., 2014). The high 
expression of water transporting membrane proteins has also led many authors to suggest 
that astrocytes are more susceptible to swelling than neurons when the capacity for RVD 
is exhausted (Häussinger, 2000; Bosoi and Rose, 2013; Papadopoulos and Verkman, 
2013; Thrane et al., 2015).  
  
Astrocyte swelling and brain edema 
On a larger scale, brain edema is believed to preferentially enter via astrocyte 
membranes by virtue of their strategic perivascular location and high water permeability 
(Papadopoulos and Verkman, 2013). A range of studies have shown that deleting or 
inhibiting AQP4 reduces the amount of brain edema following many types of insults, 
including hypoosmotic stress, stroke, traumatic brain injury, hepatic (but not 
hyperammonemic) encephalopathy and meningitis (Manley et al., 2000; Amiry-
Moghaddam et al., 2003; Papadopoulos and Verkman, 2005; Fukuda et al., 2013; 
Rangroo Thrane et al., 2013; Rao et al., 2014). Conversely, AQP4 deletion can also slow 
edema resorption, and this mechanism likely explains why AQP4-/- animals display worse 
vasogenic edema compared to AQP4+/+ animals in the context of tumors, abscesses and 
following subarachnoid hemorrhage (Papadopoulos et al., 2004; Bloch et al., 2005; Tait 
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et al., 2010). Astrocyte swelling is accompanied by a shift of fluid from either interstitial 
or intravascular to the intracellular (astrocytic) compartment (Thrane et al., 2014). This 
fluid shift can have several detrimental effects. Net fluid entry to the brain from the 
vascular compartment (vasogenic or osmotic edema) increases the brain volume, raising 
intracranial pressure, and causing potentially fatal brainstem compression; complications 
which develop in 25% of patients with ALF (Lee, 2012). However, astrocyte swelling 
can hypothetically also occur if there is an isolated fluid shift from the interstitial to the 
intracellular (cytosol) compartment, with no net fluid entry into the brain. This is termed 
cytotoxic edema, and when seen in isolation it does by definition not lead to raised 
intracranial pressure (Simard et al., 2007). However, this definition of cytotoxic edema is 
perhaps controversial, as cytotoxic swelling would arguably always be accompanied by 
some degree of net brain edema through other mechanisms (e.g. osmotic gradient across 
the BBB). Moreover, cytotoxic edema has several direct detrimental effects, such as 
increasing the concentration of ions and neurotransmitters in the now shrunken interstitial 
space. This can potentially lower the seizure threshold (increased [K+]o) and cause 
excitotoxicity (increased [Glutamate]o and consequent NMDA receptor activation). 
Additionally, cytotoxic edema can dilute intracellular ion and metabolite concentrations 
and thereby impair cellular metabolism. Generally, any form of tissue edema will also 
increase the distance for oxygen and metabolite diffusion, exposing micro-watershed 
areas to hypoxia (Takano et al., 2007; Thrane et al., 2013).  
 
Brain edema and the ‘glymphatic’ system  
Brain edema can also develop by net salt and water entry into the parenchyma in 
the presence of an intact BBB, termed ionic edema by some authors, to distinguish it 
from isolated (cytotoxic) extra-to-intra-cellular redistribution (Simard et al., 2007; Iliff et 
al., 2012; Thrane et al., 2014). One recent hypothesis that might explain this apparent 
paradoxical observation, proposes that physiological interstitial fluid turnover in the brain 
parenchyma is facilitated by continuous influx of peri-arterial CSF and efflux via the 
perivascular space of a subset of large veins (Iliff et al., 2012) or the recently discovered 
brain glymphatic vessels (Louveau et al., 2015). This pathway, termed the glymphatic 
system, might also explain the preponderance of astrocytes for swelling (Manley et al., 
2000; Amiry-Moghaddam et al., 2003) and the extensive molecular machinery astrocytes 
express for volume regulation (Iliff et al., 2012; Nedergaard, 2013). This hypothesis is 
also particularly interesting in the context of astrocyte swelling, because the main 
gateway for net water entry into the brain parenchyma is thought to be via the AQP4-
enriched perivascular membranes of astrocytes (Nielsen et al., 1997; Nagelhus and 
Ottersen, 2013; Papadopoulos and Verkman, 2013). Moreover, a derangement of the 
polarized perivascular expression of salt and water transporters along with decreased 
glymphatic interstitial fluid turnover appears to be a consistent feature of traumatized, 
infarcted, aged and even sleep-deprived brain tissue, which might make it more prone to 
astrocyte swelling and edema formation (Iliff et al., 2012; Wang et al., 2012; Ren et al., 
2013; Xie et al., 2013). Taken together, recent studies therefore highlight how astrocyte 
water transport, and consequently volume change, is likely to be linked to vascular 
perfusion and highly compartmentalized, with most of it happening in the small 
perivascular and perisynaptic processes, rather than astrocyte cell bodies. Future studies 
should therefore aim to use experimental models that best recapitulate the intimate neuro-
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glio-vascular interplay seen in living brain tissue extrapolating findings from cell culture 
or even brain slice studies may sometimes lead to false conclusions.  
 
Astrocyte swelling results in brain dysfunction 
Astrocyte swelling can lead to neurological dysfunction in several ways. 
Prolonged osmotic and/or metabolic stress has also been shown to cause the generation of 
reactive oxygen species (ROS), apoptotic pathways (such as mitochondrial permeability 
transition pore (MPTP)) and/or inflammatory signals (such as tumor necrosis factor-α 
(TNF-α), interferon-γ (INF-γ), transforming growth factor-β (TGF-β), matrix 
metallopeptidase-9 (MMP-9) and interleukin-6 (IL-6)) (Schliess et al., 2004; Simard et 
al., 2007; Thrane et al., 2014). These mechanisms likely have physiological, as well as 
pathophysiological consequences. For example, perisynaptic astrocyte processes swell 
briefly and reversibly during normal synaptic transmission and this is thought to represent 
buffering of extracellular potassium and sodium released by active neurons (Binder et al., 
2006; Haj-Yasein et al., 2012; Karus et al., 2015). However, prolonged osmotic stress 
and astrocyte swelling near the synapse could set up a vicious cycle where shrinkage of 
the interstitial space, volume-regulated excitotoxic neurotransmitter offloading, 
extracellular K+ accumulation, lactic acidosis, neuronal Na+ and Cl- accumulation 
impairing inhibitory neurotransmission, ROS, and inflammatory signals further 
compound brain edema by promoting astrocytes to swell more readily (Mulligan and 
MacVicar, 2006; Cauli et al., 2007; Rodrigo et al., 2010) (Figure 1).  
 
Techniques to measure brain edema  
It is evident that the development of intracranial hypertension is associated with 
brain edema in ALF, however in chronic liver disease, where intracranial hypertension is 
rarely observed, brain edema is also present (O’Grady, 2008; Rovira et al., 2008; Shah et 
al., 2008; Sugimoto et al., 2008; Bosoi et al., 2012; Bosoi and Rose, 2013; Butterworth, 
2015; Dam et al., 2015). The pressure-volume relationship between intracranial pressure 
and brain volume indicates that either low-grade edema or age-induced brain atrophy 
could explain the difference between ALF and chronic liver disease (Bosoi and Rose, 
2013). To date several methods have been used to measure brain edema (i.e. brain water 
content) either directly or indirectly: 1) Direct/absolute value of the amount of water in 
the brain can be measured through; i) dry/wet weight technique (Marmarou et al., 1978), 
ii) specific gravity method (Marmarou et al., 1978; Hayazaki et al., 1995) and iii) brain 
water mapping using magnetic resonance imaging (MRI) (Shah et al., 2003, 2008; Neeb 
et al., 2006; Dam et al., 2015); 2) Indirect/relative information regarding the content of 
water in the brain can be calculated using several advanced MRI techniques; i) 
magnetization transfer (MT), ii) diffusion weighted or tensor imaging (DWI or DTI) and 
iii) fast fluid-attenuated inversion recovery (FLAIR) Table 1) (Häussinger et al., 1994; 
Córdoba et al., 2001; Spahr et al., 2002; McPhail et al., 2012; Braissant et al., 2013; 
Cudalbu, 2013).  
The dry/wet weight and specific gravity methods are performed ex-vivo, using 
dissected tissue from sacrificed animals. The dry/wet weight method is the easiest way to 
measure the amount of water in extracted brain tissue. In this technique, brain samples 
are weighed before and after drying for 24 hours at 100°C (Marmarou et al., 1978) and 
the difference in weight reflects the amount of water (evaporated) in the tissue. Aside 
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from its simplicity, this technique is not sensitive enough for precisely measuring water 
evaporation in small regions and therefore is limited to whole or half brains (at least for 
rodents).  
The specific gravity method involves placing small pieces of brain tissue into a 
graduated cylinder containing a layered mixture (gradient) of organic solvents of known 
density (kerosene and bromobenzene). The equilibration depth of the inserted tissue is 
recorded after 2 minutes (representing the specific gravity). This technique is excellent 
for measuring small changes in water of many different (including small) brain regions. 
The initial set-up for making the kerosene/bromobenzene gradient columns is 
cumbersome, but worth the investment. Following the complex mixing process, each 
column must be carefully calibrated but can be used to measure the specific gravity of 
about 20-25 samples. The percentage of water is calculated taking into consideration the 
specific gravity of the solid dry tissue (Marmarou et al., 1978). This method provides 
absolute water content in the brain and has been shown to detect changes in water content 
of 1-2% in a rat model of chronic HE (Bosoi et al., 2012).  
Non-invasive in vivo measurements of water content in the human brain with MRI 
are often applied to explore brain swelling in human HE studies (Häussinger et al., 1994; 
Córdoba et al., 2001; Shah et al., 2003, 2008; Rovira et al., 2008). MRI is a non-invasive 
technique applicable in vivo and therefore be implicated in longitudinally studies on the 
same individual. MRI is primarily focused on imaging the single proton of the hydrogen 
nucleus (1H). Since hydrogen is by far the most common nucleus in the human body, it 
has become a valuable target for in vivo imaging. Several refined MRI techniques are 
presently available to detect subtle changes of approximately 1% in total brain water 
content. MT, FLAIR and DWI imaging are all sensitive to changes in brain tissue water 
of ~1 %. Although sufficiently sensitive, they all lack specificity in regards the etiology 
of the water accumulation. MT and FLAIR are both sensitive to exchange properties 
between bound and free protons, and therefore the output is determined by factors besides 
the total water content. The images, therefore, provide only indirect evidence of brain 
swelling. DWI allows the mapping of the diffusion process of primarily water molecules. 
However, molecular diffusion in tissues is not free, but reflects interactions with, for 
example, macromolecules, fibers, membranes. DWI can demonstrate changes in intra- or 
extracellular volume but no firm conclusions on the absolute water content can be drawn. 
Hence, the direct assessment of cerebral water changes in HE is tedious. A quantitative 
estimation of brain tissue water contents (water mapping) was validated on 1.5 and 3 
Tesla platforms in Juelich in Germany from 2004-2008 (Neeb et al., 2006; Shah et al., 
2008). This water mapping method enables an automated assessment of global water 
content changes in both grey and white matter as well as changes in the spatial 
distribution of water in the brain. It is sensitive and specific and can be performed within 
a clinically relevant measurement time (less 20 min). The water mapping method was 
applied to fifty-four patients with various grades of HE in 2008 (Shah et al., 2008).The 
average white matter water content was 2.1% higher in patients with overt HE compared 
to the healthy control group. There was no significant difference in grey matter water.   
In conclusion, we believe that brain water mapping is the most precise and accurate 
method that can be applied to patients with HE for absolute quantification of their 
cerebral hydration status. However, increased water content remains an unspecific 
phenomenon that also occurs in trauma, tumors, focal inflammation and late stages of 
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cerebral ischemia. For measuring brain edema in animal models a multimodal approach 
would be the most suitable. For example, an approach combining in vivo and longitudinal 
measurements with an ex vivo technique measuring the absolute water value in the brain. 
This combination allows monitoring of the progression of the syndrome longitudinally 
and therefore provides additional information on the temporal resolution of the onset of 
brain edema. Since none of these techniques provides information on the type of the 
edema or which cell is involved, it would be also very useful to combine these techniques 
with electron microscopy (Kato et al., 1992).  
 
Measuring hepatic encephalopathy in rodents; neurophenotyping 
 In humans, diagnosing HE, in particular minimal/covert HE, involves using 
sophisticated neuropsychometric and neurophysiological tests, such as the psychometric 
hepatic encephalopathy score (PHES) (Weissenborn et al., 2001; Ferenci et al., 2002; 
Amodio et al., 2008), the inhibitory control test (ICT) (Bajaj et al., 2007), the critical 
flicker frequency (CFF) test (Kircheis et al., 2002), the continuous reaction time (CRT) 
(Lauridsen et al., 2013) and the EncephalApp (Smart-phone based Stroop test) (Bajaj et 
al., 2013). Overall, these tests evaluate cognition, psychomotor processing speed, 
visuomotor coordination, memory, attention as well as motor function. As with HE 
patients, the best methods to evaluate HE in rodents are through the use of various 
behavioral tests (neurophenotyping). In general, behavioral measurements in rodents can 
be divided into three categories : 1) Cognitive function/learning and memory; 2) Motor 
function: and 3) Anxiety (Table 2). In the following sections, different tests used to 
evaluate the parameters in each category are discussed.  
 
Cognitive function/learning and memory 
Eight-Arm Maze 
This test (Olton and Samuelson, 1976), which assesses spatial memory, consists 
of eight horizontal arms placed radially around a central platform above the floor. Food is 
placed at the end of all arms, and the animal must learn to enter each arm a single time. 
Errors are defined as repeat entries into already-visited arms. Although the simplest 
strategy to solve this task would be to enter adjacent arms, rodents do not typically adopt 
this tactic. As such, the analysis of arm entries can yield insight into such processes as 
planning and decision making and impulsivity in the rodent. Different variables are 
commonly used for the analysis of the performance, including: number of errors in each 
session (entering an arm that has been visited previously counted as an error) and the 
total number of errors during eight sessions; number of correct choices in the first eight 
arm entries; location of the first error in each session; time taken to visit each arm (total 
time to complete the session divided by the total number of arm entries); number of 
sessions to reach the criterion of one error or less, averaged over four consecutive days of 
training.  Since the task is motivated by appetite, food restriction regimen are required, 
which represents a disadvantage of this behavioral test. Indeed, food restriction contrasts 
with cognitive tasks which are aversively motivated. 
 
Morris Water Maze 
This is a behavioral procedure widely used to study spatial learning and memory 
(Morris, 1984; D’Hooge and Deyn, 2001). Animals are placed into a pool of water in 
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which a platform is hidden beneath the surface. The animal must learn to use spatial cues 
located in the testing room to navigate to the platform. Longer latencies indicate poorer 
performance. Variations in the experimental protocol allow the experimenter to 
determine whether the observed impairments are the result of working (more than once a 
day) or reference memory (once a day) systems. Cognitive flexibility can be assessed 
using a water maze paradigm in which the hidden platform is continually re-located. The 
earliest measure of learning is escape latency, which is the time it takes to find the 
platform. However, this measure is confounded by swimming speed, not necessarily a 
cognitive factor. Path length between point of origin and platform is a parameter more 
closely related to spatial learning. Stress of swimming may be a disadvantage of this test. 
 
Object Recognition test 
This is a fast and efficient test to assess working memory (Ennaceur and Delacour, 1988). 
The animal is first placed into an arena containing two identical objects. After a 
predetermined period of exploration, the animal is removed from the arena, and a delay is 
imposed. Following the delay, the animal is placed back into the arena, where one of the 
objects has been replaced by a novel object. Since rodents are curious, they typically 
avoid familiar objects and explore novel objects. The amount of time investigating the 
novel object is taken as the measure of working memory. Lower exploration of the novel 
object is thus interpreted as poorer working memory performance (for further details: 
(Antunes and Biala, 2011). 
 
Motor function 
Locomotor activity 
This test is commonly used in rodents to qualitatively and quantitatively measure general 
locomotor activity and willingness to explore (Denenberg, 1969; Stanford, 2007). This 
test uses an arena with walls to prevent escape. Generally, the field is marked with a grid 
and square crossings. This test measures exploratory behavior in a novel, enclosed 
environment. Rearing and time spent moving are used to assess the activity of the rodent. 
The apparatus is equipped with infrared beams or video cameras with associated software 
that can be used to automate the assessment process. 
 
Rotarod 
The rotarod test is used to assess motor coordination and balance (Jones and Roberts, 
1968). The test animal (usually a rodent) is placed on a cylinder that rotates at gradually 
increasing speed until the animal can no longer maintain itself on the cylinder. The speed 
of the rotarod may either be held constant or accelerated. The length of time that a given 
animal stays on the rotating rod is a measure of its balance and coordination. However, 
the physical condition of the animal may represent a bias to the analysis.  
 
Arm Grip test 
This test measures forepaw strength (Meyer et al., 1979). Animals are allowed to grasp 
the grip strength meter with their forepaws. They are then gently pulled from the base of 
the tail until the grip is released. A grip strength meter measures the maximum force 
applied to the meter. 
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Gait 
This test consists of images of the underside of the animal that are taken as the animal 
ambulates on a clear treadmill. Measurements of stride length, base width, and fore and 
hind paw overlap give an indication of gait. 
 
Anxiety 
Elevated Plus Maze 
This test has become the benchmark for assessing anxiety in rodents (Pellow et al., 1985). 
The test creates an approach-avoidance conflict between the natural tendency of the 
rodent to explore and its aversion for open spaces. The elevated plus maze itself consists 
of two enclosed arms and two open arms (arms without walls). Anxiety is typically 
measured by the amount of time the animal explores the open arms. The more anxious 
the animal, the less it will explore the open arms. 
 
Open Field test 
This test, which is used to assess motor function (see previous section), may also be used 
to assess anxiety (Prut and Belzung, 2003). The latter is assessed by including additional 
measures of defecation, time spent in the center of the field and the first few minutes of 
activity. Anxiety is measured by the amount of time the animal avoids the exposed center 
area of the field and remains in close proximity to the walls.  
 
In conclusion, evaluating the behavioral phenotype in rodent models of liver disease is a 
valid way to define the presence of HE. However, due to costs, space and infrastructure, 
neurophenotyping is not routinely performed in laboratories. Furthermore, with 
increasing use of these protocols, standardizing these tests will be an imperative.  
 
Hepatic encephalopathy and brain edema  
Undoubtedly, in the development of intracranial hypertension in ALF, brain 
edema plays a “physical” contributing role to the associated encephalopathy. However 
the pathophysiological role of astrocyte swelling/brain edema in neurological 
deterioration remains elusive. Even in the absence of intracranial hypertension, it is 
suggested that astrocyte swelling can have important functional consequences and that 
HE represents a clinical manifestation of astrocyte swelling (Häussinger, 2000). 
It is well documented that cirrhotic patients with brain edema present HE (Kumar et al., 
2008; O’Grady, 2008; Rovira et al., 2008; Shah et al., 2008; Sugimoto et al., 2008; Bosoi 
and Rose, 2013; Dam et al., 2015, 2015) 
. However, it is not known whether all patients with HE have an increase in brain water. 
In rats with bile-duct ligation (BDL)-induced CLD, a type-C model of HE, brain edema 
and HE are present (Bosoi et al., 2014). However, rats with portacaval anastomosis 
(PCA), a type-B model of HE, brain edema is not present (Bosoi et al., 2012). This raises 
the question regarding the role of brain edema in the neurological alterations related to 
HE. Other studies suggest that brain edema is not implicated in the pathogenesis of HE; 
in rats with ALF, it was shown that following attenuation of brain edema with the 
hypertonic solution mannitol, motor tract function did not improve (Oria et al., 2010). In 
addition, the same authors demonstrated that following an acute injection of ammonia to 
PCA rats, severe alterations of the motor tract function developed, without the 
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development of brain edema (Oria et al., 2010). It is however worth noting that in this 
study, attenuation in brain water was only measured in the cortex and brain stem whereas 
brain water content in the red nucleus, substantia nigra and basal ganglia (regions 
implicated in the modulation of the motor tract function) were not evaluated. In another 
study by Wright and colleagues, BDL and sham-operated controls were challenged with 
lipopolysaccharides (LPS) and both groups developed brain edema. However, only the 
BDL rats presented with a neurological decline (Wright et al., 2007). In addition, acute 
hyperammonemia induced in mice resulted in severe encephalopathy without brain 
edema or astrocyte swelling (Rangroo Thrane et al., 2013). Furthermore, Aqp4-/- mice 
have 2-3% increased brain water content compared to wild-type animals, but no obvious 
neurological phenotype (Nagelhus and Ottersen, 2013).  However, there are many studies 
implicating brain edema in the pathogenesis of HE. Rovira et al., elegantly demonstrated 
a decrease in brain volume and improvement in HE following liver transplantation 
(Rovira et al., 2007). Furthermore, BDL rats treated with ammonia-lowering agents or 
antioxidants result in an attenuation in brain edema as well as an improvement in 
neurological status (Bosoi et al., 2011, 2012). Whether these discrepancies are model-
specific (i.e. HE type A vs B vs C) remains to be determined.  
 
Conclusion 
The role of brain edema, as a neuropathological feature or a cause of HE, remains 
a controversial topic. The correlation between brain edema and HE is strong, with ample 
supporting studies demonstrating that brain edema leads to neuronal dysfunction. We 
suggest that different degrees of astrocyte swelling/brain edema may inflict differential 
effects (physical stress as well as metabolic alterations) on cerebral function. Therefore, 
brain edema remains a valid endpoint in the evaluation of HE.  However, in the setting of 
liver disease/failure, other factors in addition to brain edema may play a role in the 
severity of HE. In effect, brain edema may play a predisposing or precipitating role in the 
pathogenesis of severe/overt HE.  
Understanding the obvious limitations of assessing similar neuropsychological 
tests to rodents as in humans, the worthiest assessment of HE in rodents remains 
evaluating behavioural changes. Measuring changes in cognitive function, learning, 
memory, anxiety and motor function are valid parameters in the assessment of HE. In 
fact, developing and standardizing a battery of tests to assess HE in small animals is 
highly warranted and worth considering in the future.      
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Figure 1. Effects of astrocyte swelling on brain function. Left, physiological salt and water turnover in 
the brain is functionally and anatomically compartmentalized to the peri-synaptic and peri-vascular regions. 
Right, proposed effects of astrocyte swelling on brain function include both acute alterations in ion 
concentrations, metabolism and blood flow, followed by more chronic or adaptive changes in transporter 
expression and polarization. Glutamate (Glu), interstitial fluid (ISF), intracellular fluid (ICF), adenosine 
triphosphate (ATP), reactive oxygen species (ROS), blood-brain barrier (BBB), cerebrospinal fluid (CSF), 
perivascular space (PVS), aquaporin 4 (AQP4), solute carrier family protein (SLC, e.g. Na+-K+-Cl--
cotransporter), zonula occludens (ZO, tight junctions), connexin (CNX, gap junctions), Na+-K+-ATPase, N-
methyl-D-aspartate receptor (NMDAR), pericyte (Peri.) 
 
Figure 1
Table 1: Short description of different techniques used to measure brain edema.  
 
Technique Type of 
measurement 
Edema 
measurement 
Type of 
edema 
Cell Specificity 
Water 
mapping 
Direct – in vivo 
Longitudinal 
% value no No 
Dry/wet 
weight 
Direct – ex vivo 
End point 
% value no No 
Specific 
gravity 
Direct – ex vivo 
End point 
% value no No 
DTI Indirect – in vivo 
Longitudinal 
n/a indication indication 
MT, FLAIR Indirect – in vivo 
Longitudinal 
n/a No No 
Electron 
microscopy 
Direct – ex vivo 
End point 
n/a No Yes 
 
DTI: diffusion tensor imaging; MT : magnetization transfer; FLAIR : fast fluid-
attenuated inversion recovery 
Table 1
Table 2 : Behavioral measurements in rodents 
Category Test 
Cognitive function/Learning and memory Eight-Arm Maze 
Morris Water Maze 
Object recognition test 
Motor function Locomotor activity 
Rotarod 
Arm Grip 
Gait 
Anxiety Elevated Plus Maze 
Open Field 
 
Table 2
